Literature DB >> 12142436

Mutations in the Bacillus subtilis glnRA operon that cause nitrogen source-dependent defects in regulation of TnrA activity.

Susan H Fisher1, Lewis V Wray.   

Abstract

The Bacillus subtilis nitrogen transcriptional factor TnrA is inactive in cells grown with excess nitrogen, e.g., glutamine or glutamate plus ammonium, because feedback-inhibited glutamine synthetase (product of glnA) binds to TnrA and blocks its DNA-binding activity. Two conditional mutations that allow TnrA-dependent gene expression in cells grown with glutamate plus ammonium, but not in glutamine-grown cells, were characterized. One mutant contained a mutation in the glnA ribosome binding site, while the other mutant synthesized a truncated GlnR protein that constitutively repressed glnRA expression. The levels of glutamine synthetase were reduced in both mutants. As a result, when these mutants are grown with excess nitrogen in the absence of glutamine, there is insufficient production of the feedback inhibitors necessary to convert glutamine synthetase into its feedback-inhibited form and TnrA-activated genes are expressed at high levels.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142436      PMCID: PMC135256          DOI: 10.1128/JB.184.16.4636-4639.2002

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  17 in total

1.  Bacillus subtilis glutamine synthetase controls gene expression through a protein-protein interaction with transcription factor TnrA.

Authors:  L V Wray; J M Zalieckas; S H Fisher
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

2.  Sequence of the Bacillus subtilis glutamine synthetase gene region.

Authors:  M A Strauch; A I Aronson; S W Brown; H J Schreier; A L Sonenhein
Journal:  Gene       Date:  1988-11-30       Impact factor: 3.688

3.  Regulation of Bacillus subtilis glutamine synthetase gene expression by the product of the glnR gene.

Authors:  H J Schreier; S W Brown; K D Hirschi; J F Nomellini; A L Sonenshein
Journal:  J Mol Biol       Date:  1989-11-05       Impact factor: 5.469

4.  Regulation of histidine and proline degradation enzymes by amino acid availability in Bacillus subtilis.

Authors:  M R Atkinson; L V Wray; S H Fisher
Journal:  J Bacteriol       Date:  1990-09       Impact factor: 3.490

Review 5.  Regulation of nitrogen metabolism in Bacillus subtilis: vive la différence!

Authors:  S H Fisher
Journal:  Mol Microbiol       Date:  1999-04       Impact factor: 3.501

6.  Regulation of expression from the glnA promoter of Bacillus subtilis requires the glnA gene product.

Authors:  H J Schreier; S H Fisher; A L Sonenshein
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  Bacillus subtilis glutamine synthetase mutants pleiotropically altered in glucose catabolite repression.

Authors:  S H Fisher; A L Sonenshein
Journal:  J Bacteriol       Date:  1984-02       Impact factor: 3.490

8.  Unique features in the ribosome binding site sequence of the gram-positive Staphylococcus aureus beta-lactamase gene.

Authors:  J R McLaughlin; C L Murray; J C Rabinowitz
Journal:  J Biol Chem       Date:  1981-11-10       Impact factor: 5.157

9.  Bacillus subtilis requires a "stringent" Shine-Dalgarno region for gene expression.

Authors:  L Band; D J Henner
Journal:  DNA       Date:  1984

10.  Altered regulation of the glnA gene in glutamine synthetase mutants of Bacillus subtilis.

Authors:  H J Schreier; A L Sonenshein
Journal:  J Bacteriol       Date:  1986-07       Impact factor: 3.490

View more
  2 in total

1.  Enhancement of glutamine utilization in Bacillus subtilis through the GlnK-GlnL two-component regulatory system.

Authors:  Takenori Satomura; Daisuke Shimura; Kei Asai; Yoshito Sadaie; Kazutake Hirooka; Yasutaro Fujita
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

2.  Novel antibiofilm chemotherapies target nitrogen from glutamate and glutamine.

Authors:  Tal Hassanov; Iris Karunker; Nitai Steinberg; Ayelet Erez; Ilana Kolodkin-Gal
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.